STARRETT L S CO000009367606-302023Q3false00000936762022-07-012023-03-310000093676us-gaap:CommonClassAMember2023-04-24xbrli:shares0000093676us-gaap:CommonClassBMember2023-04-2400000936762023-03-31iso4217:USD00000936762022-06-300000093676us-gaap:CommonClassAMember2023-03-31iso4217:USDxbrli:shares0000093676us-gaap:CommonClassAMember2022-06-300000093676us-gaap:CommonClassBMember2022-06-300000093676us-gaap:CommonClassBMember2023-03-3100000936762023-01-012023-03-3100000936762022-01-012022-03-3100000936762021-07-012022-03-31xbrli:pure0000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-06-300000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-06-300000093676us-gaap:AdditionalPaidInCapitalMember2022-06-300000093676us-gaap:RetainedEarningsMember2022-06-300000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000093676us-gaap:RetainedEarningsMember2022-07-012022-09-300000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-3000000936762022-07-012022-09-300000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-07-012022-09-300000093676us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-07-012022-09-300000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-09-300000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-09-300000093676us-gaap:AdditionalPaidInCapitalMember2022-09-300000093676us-gaap:RetainedEarningsMember2022-09-300000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-3000000936762022-09-300000093676us-gaap:RetainedEarningsMember2022-10-012022-12-310000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-10-012022-12-3100000936762022-10-012022-12-310000093676us-gaap:AdditionalPaidInCapitalMember2022-10-012022-12-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-10-012022-12-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-10-012022-12-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-12-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-12-310000093676us-gaap:AdditionalPaidInCapitalMember2022-12-310000093676us-gaap:RetainedEarningsMember2022-12-310000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-3100000936762022-12-310000093676us-gaap:RetainedEarningsMember2023-01-012023-03-310000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-01-012023-03-310000093676us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-01-012023-03-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-03-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-03-310000093676us-gaap:AdditionalPaidInCapitalMember2023-03-310000093676us-gaap:RetainedEarningsMember2023-03-310000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-06-300000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-06-300000093676us-gaap:AdditionalPaidInCapitalMember2021-06-300000093676us-gaap:RetainedEarningsMember2021-06-300000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-3000000936762021-06-300000093676us-gaap:RetainedEarningsMember2021-07-012021-09-300000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-3000000936762021-07-012021-09-300000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-07-012021-09-300000093676us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-07-012021-09-300000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-09-300000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-09-300000093676us-gaap:AdditionalPaidInCapitalMember2021-09-300000093676us-gaap:RetainedEarningsMember2021-09-300000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-3000000936762021-09-300000093676us-gaap:RetainedEarningsMember2021-10-012021-12-310000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-012021-12-3100000936762021-10-012021-12-310000093676us-gaap:AdditionalPaidInCapitalMember2021-10-012021-12-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-10-012021-12-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-10-012021-12-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-12-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2021-12-310000093676us-gaap:AdditionalPaidInCapitalMember2021-12-310000093676us-gaap:RetainedEarningsMember2021-12-310000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-3100000936762021-12-310000093676us-gaap:RetainedEarningsMember2022-01-012022-03-310000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-01-012022-03-310000093676us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-01-012022-03-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-03-310000093676us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-03-310000093676us-gaap:AdditionalPaidInCapitalMember2022-03-310000093676us-gaap:RetainedEarningsMember2022-03-310000093676us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-3100000936762022-03-31scx:segment0000093676scx:NorthAmericanSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000093676us-gaap:OperatingSegmentsMemberscx:InternationalMember2023-01-012023-03-310000093676scx:CorporateAndReconcilingItemsMember2023-01-012023-03-310000093676scx:NorthAmericanSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000093676us-gaap:OperatingSegmentsMemberscx:InternationalMember2022-01-012022-03-310000093676scx:CorporateAndReconcilingItemsMember2022-01-012022-03-310000093676scx:NorthAmericanSegmentMemberus-gaap:IntersegmentEliminationMember2023-01-012023-03-310000093676us-gaap:IntersegmentEliminationMemberscx:InternationalMember2023-01-012023-03-310000093676scx:NorthAmericanSegmentMemberus-gaap:IntersegmentEliminationMember2022-01-012022-03-310000093676us-gaap:IntersegmentEliminationMemberscx:InternationalMember2022-01-012022-03-310000093676scx:NorthAmericanSegmentMemberus-gaap:OperatingSegmentsMember2022-07-012023-03-310000093676us-gaap:OperatingSegmentsMemberscx:InternationalMember2022-07-012023-03-310000093676scx:CorporateAndReconcilingItemsMember2022-07-012023-03-310000093676scx:NorthAmericanSegmentMemberus-gaap:OperatingSegmentsMember2021-07-012022-03-310000093676us-gaap:OperatingSegmentsMemberscx:InternationalMember2021-07-012022-03-310000093676scx:CorporateAndReconcilingItemsMember2021-07-012022-03-310000093676scx:NorthAmericanSegmentMemberus-gaap:IntersegmentEliminationMember2022-07-012023-03-310000093676us-gaap:IntersegmentEliminationMemberscx:InternationalMember2022-07-012023-03-310000093676scx:NorthAmericanSegmentMemberus-gaap:IntersegmentEliminationMember2021-07-012022-03-310000093676us-gaap:IntersegmentEliminationMemberscx:InternationalMember2021-07-012022-03-310000093676scx:NorthAmericanSegmentMembercountry:US2023-01-012023-03-310000093676scx:NorthAmericanSegmentMembercountry:US2022-01-012022-03-310000093676scx:NorthAmericanSegmentMembercountry:US2022-07-012023-03-310000093676scx:NorthAmericanSegmentMembercountry:US2021-07-012022-03-310000093676scx:CanadaAndMexicoMemberscx:NorthAmericanSegmentMember2023-01-012023-03-310000093676scx:CanadaAndMexicoMemberscx:NorthAmericanSegmentMember2022-01-012022-03-310000093676scx:CanadaAndMexicoMemberscx:NorthAmericanSegmentMember2022-07-012023-03-310000093676scx:CanadaAndMexicoMemberscx:NorthAmericanSegmentMember2021-07-012022-03-310000093676scx:NorthAmericanSegmentMember2023-01-012023-03-310000093676scx:NorthAmericanSegmentMember2022-01-012022-03-310000093676scx:NorthAmericanSegmentMember2022-07-012023-03-310000093676scx:NorthAmericanSegmentMember2021-07-012022-03-310000093676country:BRscx:InternationalSegmentMember2023-01-012023-03-310000093676country:BRscx:InternationalSegmentMember2022-01-012022-03-310000093676country:BRscx:InternationalSegmentMember2022-07-012023-03-310000093676country:BRscx:InternationalSegmentMember2021-07-012022-03-310000093676country:GBscx:InternationalSegmentMember2023-01-012023-03-310000093676country:GBscx:InternationalSegmentMember2022-01-012022-03-310000093676country:GBscx:InternationalSegmentMember2022-07-012023-03-310000093676country:GBscx:InternationalSegmentMember2021-07-012022-03-310000093676country:CNscx:InternationalSegmentMember2023-01-012023-03-310000093676country:CNscx:InternationalSegmentMember2022-01-012022-03-310000093676country:CNscx:InternationalSegmentMember2022-07-012023-03-310000093676country:CNscx:InternationalSegmentMember2021-07-012022-03-310000093676scx:AustraliaAndNewZealandMemberscx:InternationalSegmentMember2023-01-012023-03-310000093676scx:AustraliaAndNewZealandMemberscx:InternationalSegmentMember2022-01-012022-03-310000093676scx:AustraliaAndNewZealandMemberscx:InternationalSegmentMember2022-07-012023-03-310000093676scx:AustraliaAndNewZealandMemberscx:InternationalSegmentMember2021-07-012022-03-310000093676scx:InternationalSegmentMember2023-01-012023-03-310000093676scx:InternationalSegmentMember2022-01-012022-03-310000093676scx:InternationalSegmentMember2022-07-012023-03-310000093676scx:InternationalSegmentMember2021-07-012022-03-310000093676scx:AustraliaAndNewZealandMember2022-12-310000093676scx:The2012StockIncentivePlanMember2023-01-012023-03-310000093676scx:The2012StockIncentivePlanMember2022-07-012023-03-310000093676scx:The2012StockIncentivePlanMember2022-01-012022-03-310000093676scx:The2012StockIncentivePlanMember2021-07-012022-03-310000093676us-gaap:TrademarksAndTradeNamesMember2023-03-310000093676us-gaap:TrademarksAndTradeNamesMember2022-06-300000093676us-gaap:CustomerRelationshipsMember2023-03-310000093676us-gaap:CustomerRelationshipsMember2022-06-300000093676scx:SoftwareDevelopementMember2023-03-310000093676scx:SoftwareDevelopementMember2022-06-300000093676us-gaap:OtherIntangibleAssetsMember2023-03-310000093676us-gaap:OtherIntangibleAssetsMember2022-06-300000093676us-gaap:ComputerSoftwareIntangibleAssetMember2022-07-012023-03-310000093676us-gaap:TrademarksAndTradeNamesMember2022-07-012023-03-31scx:plan0000093676us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310000093676us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-03-310000093676us-gaap:PensionPlansDefinedBenefitMember2022-07-012023-03-310000093676us-gaap:PensionPlansDefinedBenefitMember2021-07-012022-03-310000093676scx:PostRetirementMedicalPlanMember2023-01-012023-03-310000093676scx:PostRetirementMedicalPlanMember2022-01-012022-03-310000093676scx:PostRetirementMedicalPlanMember2022-07-012023-03-310000093676scx:PostRetirementMedicalPlanMember2021-07-012022-03-310000093676country:USus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310000093676us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310000093676country:USus-gaap:PensionPlansDefinedBenefitMember2022-07-012023-03-310000093676us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2022-07-012023-03-310000093676country:USus-gaap:PensionPlansDefinedBenefitMember2022-06-300000093676us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2022-06-300000093676scx:LoanAndSecurityAgreementTermLoanMember2023-03-310000093676scx:LoanAndSecurityAgreementTermLoanMember2022-06-300000093676scx:BrazilLoansMember2023-03-310000093676scx:BrazilLoansMember2022-06-300000093676scx:LoanAndSecurityAgreementTermLoanMember2023-03-310000093676scx:LoanAndSecurityAgreementTermLoanMember2022-06-300000093676us-gaap:LineOfCreditMember2023-03-310000093676us-gaap:LineOfCreditMember2022-06-300000093676scx:BrazilLoansMember2023-03-310000093676scx:BrazilLoansMember2022-06-300000093676scx:HSBCBankUSAMember2022-04-292022-04-290000093676us-gaap:RevolvingCreditFacilityMemberscx:TheCreditFacilityMember2022-04-290000093676scx:CapitalExpenditureDrawDownCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2022-04-290000093676scx:LoanAndSecurityAgreementTermLoanMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2022-04-290000093676scx:LoanAndSecurityAgreementTermLoanMemberus-gaap:LineOfCreditMemberscx:TermLoanMember2022-04-290000093676scx:LoanAndSecurityAgreementTermLoanMemberus-gaap:LineOfCreditMemberscx:TermLoanMember2022-04-292022-04-290000093676scx:LoanAndSecurityAgreementTermLoanMemberus-gaap:LineOfCreditMemberscx:CapitalExpenditureDrawDownCreditFacilityMember2022-04-290000093676scx:LoanAndSecurityAgreementTermLoanMemberus-gaap:LineOfCreditMember2022-04-290000093676scx:FourPointFiveTwoPercentShortTermLoanMemberscx:ItauBankMember2023-03-310000093676scx:FourPointNineEightPercentShortTermLoanMemberscx:ItauBankMember2023-03-310000093676scx:FourPointNineFivePercentShortTermLoanMemberscx:BrasilBankMember2023-03-310000093676scx:ThreePointEightZeroPercentShortTermLoanMemberscx:BrasilBankMember2023-03-310000093676scx:BrasilBankMemberscx:FourPointOneEightPercentShortTermLoanMember2023-03-310000093676us-gaap:SecretariatOfTheFederalRevenueBureauOfBrazilMemberus-gaap:ForeignCountryMember2023-01-012023-03-310000093676us-gaap:SecretariatOfTheFederalRevenueBureauOfBrazilMemberus-gaap:ForeignCountryMember2022-01-012022-03-310000093676us-gaap:SecretariatOfTheFederalRevenueBureauOfBrazilMemberus-gaap:ForeignCountryMember2022-07-012023-03-310000093676us-gaap:SecretariatOfTheFederalRevenueBureauOfBrazilMemberus-gaap:ForeignCountryMember2021-07-012022-03-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-Q
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period endedMarch 31, 2023
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period fromto
Commission file number1-367
THE L. S. STARRETT COMPANY
(Exact name of registrant as specified in its charter)
Massachusetts04-1866480
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
121 Crescent Street, Athol, Massachusetts
01331-1915
(Address of principal executive offices)(Zip Code)
Registrant's telephone number, including area code
978-249-3551
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Common - $1.00 Per Share Par ValueSCXNew York Stock Exchange
Class B Common - $1.00 Per Share Par ValueNot applicableNot applicable 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒    No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes ☒     No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definition of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.  (Check One):
Large Accelerated Filer ☐ Accelerated Filer ☐ Non-Accelerated Filer ☐ Smaller Reporting Company ☒
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐    No ☒
Common Shares outstanding as ofApril 24, 2023
Class A Common Shares6,835,043
Class B Common Shares590,592


FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements that involve substantial risks and uncertainties. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, our clinical results and other future conditions. The words “anticipate”, “believe”, “contemplate”, “continue”, “could”, “estimate”, “expect”, “forecast”, “goal”, “intend”, “may”, “plan”, “potential”, “predict”, “project”, “should”, “target”, “will”, “would”, or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

Any forward-looking statements in this Quarterly Report on Form 10-Q reflect our current views with respect to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed in our Annual Report on Form 10-K and other filings with the Securities Exchange Commission (the “SEC”). You should carefully review and consider the information regarding certain factors which could materially affect our business, financial condition or future results set forth under Item 1A. “Risk Factors” in our Form 10-K for the year ended June 30, 2022.

We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make or collaborations or strategic partnerships we may enter into. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.


1

THE L. S. STARRETT COMPANY
CONTENTS
Page No.
Condensed Consolidated Balance Sheets – March 31, 2023 (unaudited) and June 30, 2022
Condensed Consolidated Statements of Stockholders' Equity (unaudited) – three and nine months ended March 31, 2023 and March 31, 2022 
6-8
10-21













2

PART I.    FINANCIAL INFORMATION
ITEM 1.    FINANCIAL STATEMENTS
THE L. S. STARRETT COMPANY
Condensed Consolidated Balance Sheets
(in thousands except share data)
(unaudited)
03/31/202306/30/2022
ASSETS
Current assets:
Cash$8,595 $14,523 
Accounts receivable (less allowance for credit losses of $846 and $796, respectively)
36,267 42,961 
Inventories67,685 66,900 
Prepaid expenses and other current assets10,073 8,669 
Total current assets122,620 133,053 
Property, plant and equipment, net38,160 37,116 
Right of use assets5,338 5,540 
Deferred tax assets, net18,793 14,924 
Intangible assets, net4,571 4,640 
Goodwill1,015 1,015 
Other assets 3,368 3,266 
Total assets$193,865 $199,554 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current maturities of debt$5,264 $6,547 
Current lease liability2,057 1,530 
Accounts payable15,006 14,624 
Accrued expenses9,767 11,776 
Accrued compensation5,553 6,703 
Total current liabilities37,647 41,180 
Other tax obligations2,850 2,936 
Long-term lease liability3,465 4,166 
Long-term debt, net of current portion9,991 24,905 
Postretirement benefit and pension obligations22,856 23,938 
Total liabilities76,809 97,125 
Stockholders' equity:
Class A Common stock $1 par (20,000,000 shares authorized; 6,818,178 outstanding at March 31, 2023 and 6,682,521 outstanding at June 30, 2022)
$6,818 $6,683 
Class B Common stock $1 par (10,000,000 shares authorized; 607,899 outstanding at March 31, 2023 and 610,087 outstanding at June 30, 2022)
608 610 
Additional paid-in capital57,627 57,143 
Retained earnings101,719 89,059 
Accumulated other comprehensive loss(49,716)(51,066)
Total stockholders' equity117,056 102,429 
Total liabilities and stockholders’ equity$193,865 $199,554 
See Notes to Unaudited Condensed Consolidated Financial Statements
3

THE L. S. STARRETT COMPANY
Condensed Consolidated Statements of Operations
(in thousands except per share data)
(unaudited)

3 Months Ended9 Months Ended
03/31/202303/31/202203/31/202303/31/2022
Net sales$61,678 $60,479 $188,914 $183,311 
Cost of goods sold42,455 39,459 127,916 123,197 
Gross profit19,223 21,020 60,998 60,114 
% of Net sales31.2 %34.8 %32.3 %32.8 %
Restructuring charges— 658 244 658 
Selling, general and administrative expenses15,109 14,988 46,962 45,750 
Operating income4,114 5,374 13,792 13,706 
Other (expense) income, net(602)684 (2,399)249 
Income before income taxes3,512 6,058 11,393 13,955 
Income tax (benefit) expense (3,961)1,774 (1,267)3,911 
Net income$7,473 $4,284 $12,660 $10,044 
Basic income per share$1.01 $0.59 $1.72 $1.39 
Diluted income per share$0.99 $0.57 $1.68 $1.34 
Weighted average outstanding shares used in per share calculations:
Basic7,427 7,256 7,379 7,208 
Diluted7,577 7,492 7,538 7,480 

See Notes to Unaudited Condensed Consolidated Financial Statements
4

THE L. S. STARRETT COMPANY
Condensed Consolidated Statements of Comprehensive Income
(in thousands)
(unaudited)

3 Months Ended9 Months Ended
03/31/202303/31/202203/31/202303/31/2022
Net income$7,473 $4,284 $12,660 $10,044 
Other comprehensive income:
Currency translation gain, net of tax1,545 6,807 1,455 2,325 
Pension and postretirement plans, net of tax(44)(89)(105)(222)
Other comprehensive income 1,501 6,718 1,350 2,103 
Total comprehensive income $8,974 $11,002 $14,010 $12,147 



See Notes to Unaudited Condensed Consolidated Financial Statements
5

THE L. S. STARRETT COMPANY
Condensed Consolidated Statements of Stockholders' Equity
(in thousands) (unaudited)
For the Three and Nine-Month Period Ended March 31, 2023:

Common Stock
Outstanding		Additional
Paid-in
Capital		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Total
Class AClass B
Balance June 30, 2022$6,683 $610 $57,143 $89,059 $(51,066)$102,429 
Total comprehensive income (loss)— — — 2,056 (2,831)(775)
Repurchase of shares— (1)(5)— — (6)
Stock-based compensation76 — 109 — — 185 
Conversion12 (12)— — — — 
Balance September 30, 2022$6,771 $597 $57,247 $91,115 $(53,897)$101,833 
Total comprehensive income (loss)— — — 3,131 2,680 5,811 
Repurchase of shares— — (3)— — (3)
Issuance of stock— 34 50 — — 84 
Stock-based compensation25 — 160 — — 185 
Conversion7 (7)— — — — 
Balance December 31, 2022$6,803 $624 $57,454 $94,246 $(51,217)$107,910 
Total comprehensive income— — — 7,473 1,501 8,974 
Repurchase of shares— (1)(6)— — (7)
Stock-based compensation— — 179 — — 179 
Conversion15 (15)— — — — 
Balance March 31, 2023$6,818 $608 $57,627 $101,719 $(49,716)$117,056 
Accumulated balance consists of:
Translation loss$(58,621)
Pension and postretirement plans, net of taxes8,905 
$(49,716)










6

THE L. S. STARRETT COMPANY
Condensed Consolidated Statements of Stockholders' Equity
(in thousands) (unaudited)

For the Three and Nine-Month Period Ended March 31, 2022:
Common Stock
Outstanding		Additional
Paid-in
Capital		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Total
Class AClass B
Balance June 30, 2021$6,475 $634 $56,507 $74,181 $(54,262)$83,535 
Total comprehensive income (loss)— — — 3,232 (3,677)(445)
Repurchase of shares— (2)(14)— — (16)
Stock-based compensation119 — 55 — — 174 
Conversion25 (25)— — — — 
Balance September 30, 2021$6,619 $607 $56,548 $77,413 $(57,939)$83,248 
Total comprehensive income (loss)— — — 2,528 (938)1,590 
Repurchase of shares— — (7)— — (7)
Issuance of stock7 8 102 — — 117 
Stock-based compensation11 — 226 — — 237 
Conversion7 (7)— — — — 
Balance December 31, 2021$6,644 $608 $56,869 $79,941 $(58,877)$85,185 
Total comprehensive income — — — 4,284 6,718 11,002 
Repurchase of shares— (3)(14)— — (17)
Stock-based compensation10 — 93 — — 103 
Conversion11 (11)— — — — 
Balance March 31, 2022$6,665 $594 $56,948 $84,225 $(52,159)$96,273 
Accumulated balance consists of:
Translation loss$(53,722)
Pension and postretirement plans, net of taxes1,563 
$(52,159)

See Notes to Unaudited Condensed Consolidated Financial Statements
7

THE L. S. STARRETT COMPANY
Condensed Consolidated Statements of Cash Flows
(in thousands) (unaudited)
9 Months Ended
03/31/202303/31/2022
Cash flows from operating activities:
Net income$12,660 $10,044 
Non-cash operating activities:
Depreciation3,884 3,913 
Amortization998 957 
Stock-based compensation549 514 
Net long-term tax obligations(66)126 
Deferred taxes(3,753)937 
Postretirement benefit and pension obligations475 (1,058)
Changes in operating assets and liabilities:
Accounts receivable7,148 (5,900)
Inventories(72)(11,053)
Other current assets(1,275)(5)
Other current liabilities(3,255)139 
Prepaid pension expense(1,574)(2,342)
Other178 937 
Net cash provided by (used in) operating activities15,897 (2,791)
Cash flows from investing activities:
Purchases of property, plant and equipment(4,790)(6,883)
Software development(795)(782)
 Intangibles-other(54)— 
Net cash (used in) investing activities(5,639)(7,665)
Cash flows from financing activities:
Proceeds from term loan borrowings575 12,433 
Proceeds from line of credit borrowings1,000 27,442 
Term debt repayments(8,352)(7,906)
 Line of credit repayments(9,500)(21,582)
Proceeds from common stock issued84 117 
Shares repurchased(16)(40)
Net cash provided by (used in) financing activities (16,209)10,464 
Effect of exchange rate changes on cash23 (1,093)
Net decrease in cash(5,928)(1,085)
Cash, beginning of period14,523 9,105 
Cash, end of period$8,595 $8,020 
Supplemental cash flow information:
Interest paid$1,200 $690 
Income taxes paid, net4,395 2,614 
8

See Notes to Unaudited Condensed Consolidated Financial Statements
9

THE L. S. STARRETT COMPANY
Notes to Unaudited Condensed Consolidated Financial Statements
March 31, 2023
Note 1:    Basis of Presentation and Summary of Significant Accounting Policies
The unaudited interim Condensed Consolidated Financial Statements as of and for the nine months ended March 31, 2023 have been prepared by The L.S. Starrett Company (the “Company”) in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements. These unaudited Condensed Consolidated Financial Statements, which, in the opinion of management, reflect all adjustments (including normal recurring adjustments) necessary for a fair presentation, should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2022. The balance sheet as of June 30, 2022 has been derived from the Audited Consolidated Financial Statements as of and for the year ended June 30, 2022. Operating results are not necessarily indicative of the results that may be expected for any future interim period or for the entire fiscal year. The Company’s “fiscal year” begins July 1st and ends June 30th.
Accounts Receivable and Allowance for Credit Losses
Trade accounts receivable are recorded at invoiced amount and do not bear interest. Allowance for doubtful accounts is the Company's estimate of current expected credit losses on its existing accounts receivable and determined based on historical customer assessments, current financial conditions and reasonable and supportable forecasts. Account balances are charged off against the allowance when the Company determines the receivable will not be recovered.
Fair Value Measurements
Certain of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and other liabilities are carried at cost, which approximates their fair value because of their short-term maturity. See Notes 10 and 11 within the notes to the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for financial assets and liabilities held at carrying amount on the Condensed Consolidated Balance Sheet.
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, assumptions and estimates that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Note 2 within the notes to the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q to the Company’s Condensed Consolidated Financial Statements included in the Annual Report on Form 10-K for the year ended June 30, 2022 describes the significant accounting policies and methods used in the preparation of the Condensed Consolidated Financial Statements.

Note 2:    Recently Adopted Accounting Pronouncements
In June 2016, the FASB issued ASU 2016-13 "Financial Instruments -Credit Losses" (ASC 326) "Measurement of Credit Losses on Financial Instruments,” and subsequent amendment to the guidance, ASU 2018-19 in November 2018. The standard significantly changes how entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The standard replaces historic incurred loss” approach with an “expected loss” model for instruments measured at amortized cost. The amendment loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. ASU 2018-19 clarifies that receivables arising from operating leases are accounted for using lease guidance and not as financial instruments. The amendments should be applied on either a prospective transition or modified-retrospective approach depending on the subtopic. This pronouncement was extended for Small Reporting Companies and for the Company beginning July 1, 2022. The adoption of this standard did not have a material impact on the Company's Condensed Consolidated Financial Statements.

10

Note 3:    Segment Information
The segment information and the accounting policies of each segment are the same as those described in the notes to the condensed consolidated financial statements entitled “Financial Information by Segment & Geographic Area” included in our Annual Report on Form 10-K for the year ended June 30, 2022. The Company’s business is aggregated into two reportable segments based on geography of operations: North American Operations "North America" and International Operations "International". Segment income is measured for internal reporting purposes by excluding corporate expenses, which are included in the unallocated column in the table below. Other income and expense, including interest income and expense, and income taxes are excluded entirely from the table below. There were no material changes in the segment operations or in the segment assets from our Annual Report on Form 10-K for the year ended June 30, 2022. Financial results for each reportable segment are as follows (in thousands):
North
American
Operations		International
Operations		UnallocatedTotal
Three Months ended March 31, 2023
Sales1
$37,053 $24,625 $— $61,678 
Operating Income (Loss)$3,435 $2,502 $(1,823)4,114 
Three Months ended March 31, 2022
Sales2
$36,288 $24,191 $— $60,479 
Operating Income (Loss)$4,663 $2,628 $(1,917)$5,374 
1.Excludes $327 of North American segment intercompany sales to the International segment, and $3,556 of International segment intercompany sales to the North American segment.
2.Excludes $1,148 of North American segment intercompany sales to the International segment, and $4,402 of International segment intercompany sales to the North American segment.
North
American
Operations		International
Operations		UnallocatedTotal
Nine Months ended March 31, 2023
Sales1
$113,223 $75,691 $— $188,914 
Operating Income (Loss)$10,314 $9,231 $(5,753)$13,792 
Nine months ended March 31, 2022
Sales2
$102,763 $80,548 $— $183,311 
Operating Income (Loss)$8,713 $10,604 $(5,611)$13,706 
1.Excludes $1,961 of North American segment intercompany sales to the International segment, and $12,841 of International segment intercompany sales to the North American segment.
2.Excludes $2,827 of North American segment intercompany sales to the International segment, and $14,150 of International segment intercompany sales to the North American segment.
Note 4:    Revenue from Contracts with Customers
Under ASC Topic 606, the Company is required to present a refund liability and a return asset within the Unaudited Condensed Consolidated Balance Sheet. As of March 31, 2023 and June 30, 2022, the balance of the return asset was $0.1 million and $0.2 million, respectively, and the balance of the refund liability as of March 31, 2023 and June 30, 2022 were both $0.2 million. They are presented within prepaid expenses and other current assets and accrued expenses, respectively, on the Condensed Consolidated Balance Sheets.
11

The Company, in general, warrants its products against certain defects in material and workmanship when used as designed, for a period of up to one year. The Company does not sell extended warranties.
Contract Balances
Contract assets primarily relate to the Company’s rights to consideration for work completed but not billed at the reporting date on contracts with customers. Contract assets are transferred to receivables when the rights become unconditional. Contract liabilities primarily relate to contracts where advance payments or deposits have been received, but performance obligations have not yet been met, and therefore, revenue has not been recognized. The Company had no contract asset balances, but had contract liability balances of $0.8 million and $0.9 million at March 31, 2023 and June 30, 2022, respectively, recorded in Accounts Payable in the Condensed Consolidated Balance Sheets.
Disaggregation of Revenue
The Company operates in two reportable segments: North America and International. ASC Topic 606 requires further disaggregation of an entity’s revenue. In the following table, the Company's net sales by shipping origin are disaggregated accordingly for the three and nine months ended March 31, 2023 and 2022 (in thousands):

Three Months EndedNine Months Ended
03/31/202303/31/202203/31/202303/31/2022
North America
United States$35,122 $34,181 $107,014 $97,049 
Canada & Mexico1,931 2,107 6,209 5,714 
37,053 36,288 113,223 102,763 
International
Brazil18,160 15,980 55,465 54,063 
United Kingdom3,563 4,750 10,059 14,254 
China1,497 1,899 5,160 5,761 
Australia & New Zealand1,405 1,562 5,007 6,469 
24,625 24,191 75,691 80,548 
Total Sales$61,678 $60,479 $188,914 $183,311 
Note 5:    Leases
Operating lease expense amounted to $0.5 million and $1.5 million for the three and nine months period ended for March 31, 2023 and March 31, 2022. For the three and nine months period ended March 31, 2022 operating lease expense was $0.5 million and $2.1 million. As of March 31, 2023, the Company’s right-of-use assets "ROU", lease obligations and remaining cash commitment on these leases (in thousands):
12


Right-of-Use
Assets		Operating Lease
Obligations		Remaining Cash
Commitment
Total leases$5,338$5,522$6,534
The Company has other operating lease agreements with commitments of less than one year or that are not material. The Company elected the practical expedient option and as such, these lease payments are expensed as incurred. The Company’s weighted average discount rate and remaining term on lease liabilities is approximately 9.0% and 3.5 years. As of March 31, 2023, the Company’s financing leases are not material. The foreign exchange impact affecting the operating leases are, also, not material.
In the three months and nine months ended March 31, 2023 the Company entered into new leases in the amount of $0.4 million and $1.2 million. During December 2022 the Company renewed its leases in both Australia (ends September 2026) and New Zealand (ends April 2025) and recorded $0.6 million in new leases as ROU assets.
At March 31, 2023, the Company had the following fiscal year minimum operating lease commitments (in thousands):
Operating Lease
Commitments
2023 (Remainder of year)$573
20242,128
20251,689
20261,335
2027715
Thereafter94
Subtotal$6,534
Imputed interest(1,012)
Total5,522
Note 6:    Stock-based Compensation
Compensation expense related to all stock-based plans for the three and nine months ended March 31, 2023 were $0.2 million and $0.5 million as compared to the prior year three and nine months of $0.1 million and $0.4 million, respectively. 
Note 7:    Inventories
Inventories consist of the following (in thousands):
03/31/202306/30/2022
Raw material and supplies$36,757 $35,752 
Goods in process and finished parts22,218 22,268 
Finished goods35,036 35,589 
94,011 93,609 
LIFO Reserve(26,326)(26,709)
$67,685 $66,900 

Of the Company’s $67.7 million and $66.9 million total inventory at March 31, 2023 and June 30, 2022, respectively, the $26.3 million and $26.7 million LIFO reserves belong to the U.S. Precision Tools and Saws Manufacturing “Core U.S.” business. The Core U.S. business total inventory was $40.1 million on a FIFO basis and $13.8 million on a LIFO basis at March 31, 2023. The Core U.S. business had total Inventory, on a FIFO basis, of $39.3 million and $12.6 million on a LIFO basis as of June 30,
13

2022. The use of LIFO, as compared to FIFO, resulted in a $0.4 million decrease in cost of sales for the goods sold in the nine months ended March 31, 2023 compared to $4.3 million increase in the nine months ended March 31, 2022.
Note 8:    Goodwill and Intangible Assets


Amortizable intangible assets consist of the following (in thousands):
03/31/20236/30/2022
Trademarks and trade names2,070 2,070 
Customer relationships630 630 
Software development12,063 11,269 
Other intangible assets55 — 
Gross intangible assets14,818 13,969 
Accumulated amortization and impairment(10,247)(9,329)
Total net balance$4,571 $4,640 
The estimated useful lives of the intangible assets subject to amortization range between 5 years for software development and 20 years for some trademark and trade name assets.
The goodwill balance at March 31, 2023, was gross $4.7 million and accumulated impairment of $3.7 million. There is no change in the three and nine months ended March 31, 2023.

Note 9:    Accrued Expenses

The following table represents accrued expenses from the Condensed Consolidated Balance Sheets (in thousands):
03/31/202306/30/2022
Sales related programs (commissions, rebates, distributor programs, warranty and related)$2,779 $2,733 
Income taxes299 2,420 
Professional fees1,799 1,758 
Other1,496 1,463 
Current portion pension cost1,299 1,289 
Taxes other than income tax1,366 1,243 
Workers compensation and employee deposits493 518 
Freight236 352 
Total$9,767 $11,776 
Note 10:     Pension and Post-retirement Benefits
The Company has two defined benefit pension plans, one for U.S. employees which was frozen for new participants in 2016 and another for U.K. employees frozen for new participants in 2009. The Company has a postretirement medical insurance benefit plan for U.S. employees which remains open. The Company also has defined contribution plans.
Net periodic benefit costs for the Company's defined benefit pension plans are located in Other (expense), net in Condensed Consolidated Statements of Operations except (in the table below) for service cost. Service cost are in cost of sales and selling, general and administrative expenses, allocated on headcount. Net periodic benefit costs consist of the following (in thousands):
14

Three Months EndedNine Months Ended
03/31/202303/31/202203/31/202303/31/2022
Interest cost1,464 1,026 4,354 3,090 
Expected return on plan assets(1,015)(1,092)(3,007)(3,290)
Amortization of net loss10 14 30 42 
Expected net cost (benefit) total$459 $(52)$1,377 $(158)
Net periodic benefit costs for the Company's Postretirement Medical Plan consists of the following (in thousands):
Three Months EndedNine Months Ended
03/31/202303/31/202203/31/202303/31/2022
Service cost$6 $9 $17 $27 
Interest cost18 12 53 37 
Amortization of prior service credit(369)(369)(1,106)(1,106)
Amortization of net loss44 48 133 142 
Total net (benefit)$(301)$(300)$(903)$(900)
For the three months ended March 31, 2023, the Company contributed $0.2 million in both the U.S. and the UK to the pension plan. For the nine month periods ended March 31, 2023, the Company contributed $0.9 million, in the U.S. and $0.7 million in the UK pension plans. Based upon the actuarial valuations performed on the Company’s defined benefit plans as of June 30, 2022, the contribution for fiscal 2023 for the U.S. plans would require a contribution of $1.4 million and the U.K. plan would require one of $0.8 million. However, as a result of the American Rescue Plan Act of 2021, the minimum required company contribution for the U.S. Plan in fiscal 2023 was reduced. The Company believes that government regulation is only a small part of deciding the pension funding, and as a result, has contributed more than the federal requirement. The Company will evaluate the U.S. future contribution on a quarterly basis.
The Company’s pension plans use fair value as the market-related value of plan assets and recognize net actuarial gains or losses in excess of ten percent (10)% of the greater of the market-related value of plan assets or of the plans’ projected benefit obligation in net periodic (benefit) cost as of the plan measurement date. Net actuarial gains or losses that are less than 10% of the thresholds noted above are accounted for as part of accumulated other comprehensive loss.
Note 11:     Debt
Debt is comprised of the following (in thousands):
03/31/202306/30/2022
Short-term and current maturities
Loan and Security Agreement (Term Loan)1,495 1,495 
Brazil Loans3,769 5,052 
Subtotal short-term and current maturities5,264 6,547 
Long-term debt (net of current portion)
Loan and Security Agreement (Term Loan)6,131 10,252 
Loan and Security Agreement (Line of Credit)2,897 11,397 
Brazil Loans1,398 3,771 
Debt reacquisition cost(435)(515)
Subtotal long-term debt9,991 24,905 
Total debt$15,255 $31,452 
On April 29, 2022, the Company and certain of the Company’s domestic subsidiaries entered into a Loan and Security agreement (the "Loan and Security Agreement") with HSBC Bank USA ("the Lender"). The Company incurred debt re-acquisition cost of $0.5 million which are recorded net of debt and amortized over five years.

15

These new credit facilities replaced the Company’s previous TD Bank credit facilities and are comprised of a $30 million revolving Loan and Security Agreement Line of Credit ("Line of Credit") with a $10 million uncommitted accordion provision, a Loan and Security Agreement Term Loan ("the Term Loan") with original principal of $12.1 million and a $7 million Capital Expenditure draw down credit facility (collectively, the "Facilities"). The Facilities are secured by a valid first-priority security interest on substantially all existing and future assets of the Company and its domestic subsidiaries.

The interest rate on the Facilities is based on a grid which uses the percentage of the remaining availability of the revolving credit line to determine the floating margin to be added to the one month or three months Secured Overnight Financing Rate, (SOFR). The Facilities mature on April 29, 2027.

Availability under the revolving line of credit is secured by and subject to a borrowing base comprised of eligible inventory and accounts receivable. The percentage of receivables included in the borrowing base is 90% for domestic investment grade and foreign insured accounts, 85% for domestic accounts that are neither investment grade nor insured, and 75% of foreign uninsured accounts. The percentage of inventory included in the borrowing base is the lower of 65% of the value of eligible inventory at cost or 85% of the net orderly liquidation value of eligible inventory at cost. Receivables and inventory are reported monthly to HSBC and subject to an annual field exam and inventory appraisal by an independent auditor commissioned by the Bank. The Company believes that the agreement provides an initial borrowing base sufficient for current domestic working capital needs and flexibility to accommodate potential growth-related working capital needs.

Availability under the Line of Credit remains subject to a borrowing base comprised of accounts receivable, inventory, and real estate. The Company believes that the borrowing base will consistently produce availability under the Line of Credit of $30.0 million. A 0.25% commitment fee is charged on the unused portion of the Line of Credit.

Availability under the Term Loan was comprised of 70% of the fair market value of the Borrower's eligible real estate, which included facilities located in Westlake, Ohio, and Waite Park, Minnesota and totaled $4.6 million; and 85% of the net orderly liquidation value of the Borrowers’ machinery and equipment, capped at $7.5 million. The real estate portion of the Term facility is subject to a 12.5 year straight line amortization paid quarterly, and the machinery and equipment portion of the facility is subject to a 6.67 year straight line amortization, also paid quarterly. The Term Loan is subject to equal quarterly installments of $373,650, payable on the last day of each fiscal quarter.

The capital expenditure loan facility is available for the purchase of new machinery and equipment at 80% of the net invoice value of new machinery and equipment purchases, with a draw period of eighteen months past the closing date, with any amount outstanding under the facility subject to a 3.75% amortization rate per quarter.

The Facilities contain financial covenants with respect to a minimum fixed charge coverage ratio of 1.00, measured on a trailing twelve-month basis, for both the U.S. borrowing companies tested quarterly and the Condensed Consolidated L.S. Starrett Company tested semi-annually. The Loan and Security agreement also contains the customary affirmative and negative covenants, including limitations on indebtedness, liens, acquisitions, asset dispositions, fundamental corporate changes, excess pension contributions, and certain customary events of default. Upon the occurrence or continuation of an event of default, the Lender may terminate all commitments and facilities, and require the immediate payment of the entire unpaid principal balances, accrued interest, and all other obligations.

The TD Bank loan was retired in the quarter ended June 2022.

In Brazil, the Company is actively mitigating this consequence of the build-up of ICMS (translate to "Tax on Commerce and Services") credits by filing applications with the relevant tax authorities to change the methodology of charging and re-claiming ICMS on imports and domestic sales so that this credit is subsequently relieved and does not increase at this rate again. The Brazilian federal tax authority has approved the Company's application and now it is awaiting state tax approval. This new methodology is common for similar sized, export focused companies in Brazil. The ICMS is an asset and its build-up was one of the reasons that the Brazilian operation initially incurred more debt. The ICMS balance as of March 31, 2023 was $5.2 million and as of June 30, 2022 was $5.4 million. The balance is located on the Condensed Consolidated Balance Sheets in prepaid expenses and other current assets.
The Company’s Brazilian subsidiary incurs short-term loans with local banks in order to support the Company’s strategic initiatives. The loans are backed by the entity’s US dollar denominated export receivables. The Company’s Brazilian subsidiary has the following loans of March 31, 2023 (in thousands):
16

Lending InstitutionInterest RateBeginning DateEnding DateOutstanding Balance
Itau4.52%October 2021September 2024$3,429 
Itau4.98%February 2022February 20241,219 
Brasil4.95%August 2022July 2025372
Brasil3.80%September 2022August 202495
Brasil4.18%September 2022September 202353
$5,168 


Note 12:     Income Taxes

Tax expense for the three months ended March 31, 2023 was a benefit of $4.0 million on profit before tax of $3.5 million (an effective tax rate of 113%). During the three months ended March 31, 2023 the Company recorded a discrete tax benefit of $5.0 million related to the Company’s partial release of its valuation allowance against its U.S. foreign tax credits and state net operating losses carryforwards, which are expected to be utilized based on demonstrated profitability and current and future forecast income. Excluding the tax benefit related to the partial release of valuation allowance of 144%, the effective tax rate for the three months ended March 31, 2023 was higher than the U.S. statutory tax rate of 21% primarily due to the GILTI provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, and non-creditable foreign withholding tax. Tax expense for the three months ended March 31, 2022, was $1.8 million on profit before tax of $6.1 million (an effective tax rate of 29%). The effective tax rate for the three months ended March 31, 2022 was higher than the U.S. statutory tax rate of 21% primarily due to the GILTI provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, offset by tax credits and permanent deductions generated from research expenses.

Tax expense for the nine months ended March 31, 2023 was a benefit of $1.3 million on profit before tax of $11.4 million (an effective tax rate of 11%). During the nine months ended March 31, 2023, the Company recorded a discrete tax benefit of $5.0 million related to the Company’s partial release of its valuation allowance against its U.S. foreign tax credits and state net operating losses carryforwards, which are expected to be utilized based on demonstrated profitability and current and future forecast income. In addition the Company used current forecasts of future taxable income. Excluding the tax benefit related to the partial release of valuation allowance of 44%, the effective tax rate for the nine months ended March 31, 2023 was higher than the U.S. statutory tax rate of 21% primarily due to the GILTI provisions and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, and non-creditable foreign withholding tax. Tax expense for the nine month period ended March 31, 2022 was $3.9 million on profit before tax of $14.0 million (an effective tax rate of 28%). The effective tax rate for the nine month period ended March 31, 2022 was higher than the U.S. statutory tax rate of 21% primarily due to the GILTI provisions, and the jurisdictional mix of earnings, particularly Brazil with a statutory rate of 34%, offset by discrete tax benefits recognized from excess stock compensation deductions, tax credits, and permanent deductions generated from research expenses.

Tax expense for the three and nine month period ended March 31, 2023 reflects the impact of final U.S. foreign tax credit regulations effective in fiscal 2023 that result in an increase in tax expense from the GILTI inclusion. In the nine months ended March 31, 2023 the GILTI impact resulted in a 5.4% rate as compared to the nine months ended March 31, 2022 resulting in a rate of 1.1%.

At the end of each reporting period management considers all evidence, both positive and negative, that could affect the view of the future realization of deferred tax assets. Based upon cumulative profitability in the US and increases in future taxable income projections, management has determined during the three months ended March 31, 2023, there is sufficient positive evidence to release a portion of valuation allowance previously provided against its foreign tax credits and certain state net operating losses. The Company continues to maintain a valuation allowance against certain foreign tax credit carryforwards and state net operating losses carryforward that are anticipated to expire unutilized and net operating losses in Australia as of March 31, 2023 and June 30, 2022. The Company had long term tax obligations related primarily to transfer pricing adjustments at March 31, 2023 and June 30, 2022.
Note 13: Contingencies
17

The Company is involved in certain legal matters, which arise, in the normal course of business. Although the outcomes of these legal matters are inherently difficult to predict, management does not expect the resolution of these legal matters to have a material adverse effect on the Company’s financial condition, results of operations or cash flows.

18

ITEM 2.    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


RESULTS OF OPERATIONS
Use of Non- GAAP Financial Measures

In "Management's discussion and analysis on financial condition and results of operations" in this Quarterly Report on Form 10-Q, we discuss non- GAAP financial measures related to currency-neutral sales, adjusted operating income, and adjusted net income and earnings per share.

We present these non- GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis by eliminating items that we do not believe are indicative of our core operating performance. Such non- GAAP financial measures assist investors in understanding the ongoing operating performance of the Company by presenting financial results between periods on a more comparable basis. Such measures should be considered in addition to, and not in lieu of, the financial measures calculated and presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Currency-neutral sales are calculated using actual exchange rates in use during the comparative prior year period to enhance the visibility of the underlying business trends excluding the impact of translation arising from foreign currency exchange rate fluctuations. Adjusted operating income adjusts for restructuring costs in order to show comparative operational performance. We include a reconciliation of currency-neutral sales and adjusted operating income to its comparable GAAP financial measures.

References to currency-neutral sales and adjusted operating income should not be considered in isolation or as a substitute for other financial measures calculated and presented in accordance with GAAP and may not be comparable to similarly titled non- GAAP financial measures used by other companies. In evaluating these non-GAAP financial measures, investors should be aware that in the future we may incur expenses or be involved in transactions that are the same as or similar to some of the adjustments in this presentation. Our presentation of non-GAAP financial measures should not be construed to imply that its future results will be unaffected by any such adjustments. Non-GAAP financial measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of our results as reported under GAAP.

Please see Note 3 within the notes to the Unaudited Condensed Consolidated Financial Statement in this Quarterly Report on Form 10-Q regarding segment results of operations. The Company’s business is aggregated into two reportable segments based on geography of operations: North American Operations and International Operations. Segment income is measured for internal reporting purposes by excluding corporate expenses, which are included in the unallocated column in the following tables as well as Note 3. These tables provided in Note 3 are included to better explain our consolidated operational performance by showing more detail by business segment and reconciling GAAP operating income and adjusted operating income.

The following table represents key results of operations on a consolidated basis for the three months and nine months ended March 31, 2023 and March 31, 2022:
19

Three Months EndedNine Months Ended
(Amounts in thousands)03/31/2303/31/22$ Change favorable (unfavorable)% Change03/31/2303/31/22$ Change favorable (unfavorable)% Change
Net sales$61,678 $60,479 $1,199 2.0 %$188,914 $183,311 $5,603 3.1 %
Gross margin19,223 21,020 (1,797)(8.5)%60,998 60,114 884 1.5 %
% of net sales31.2 %34.8 %32.3 %32.8 %
Selling, general and administrative expenses15,109 14,988 (122)(0.8)%46,962 45,750 (1,212)(2.7)%
% of net sales24.5 %24.8 %24.9 %25.0 %
Restructuring charges— 658 658 (100.0)%244 658 414 (100.0)%
Gain on sale of building— — — — %— — — 100.0 %
Operating income4,114 5,374 (1,260)(23.4)%13,792 13,706 86 0.6 %
Other income, net(602)684 (1,286)(188.0)%(2,399)249 (2,648)1064.8 %
Income before income taxes3,512 6,058 (2,546)(42.0)%11,393 13,955 (2,562)(18.4)%
Income tax expense (3,961)1,774 5,735 323.3 %(1,267)3,911 5,178 132.4 %
Net income$7,473 $4,284 3,189 74.4 %$12,660 $10,044 2,615 26.0 %
GAAP to Non-GAAP reconciliation:
Three Months EndedNine Months Ended
(Amounts in thousands)03/31/2303/31/22$ Change favorable (unfavorable)% Change03/31/2303/31/22$ Change favorable (unfavorable)% Change
Operating income as reported4,114 5,374 (1,260)(23.4)%13,792 13,706 86 0.6 %
Add back restructuring charges — 658 (658)(100.0)%244 658 (414)(62.9)%
Non- GAAP adjusted operating income4,114 6,032 (1,918)(31.8)%14,036 14,365 (329)(2.3)%
% of net sales6.7 %10.0 %7.4 %7.8 %
The following table represents key results of operations for three months ending March 31, 2023 and 2022 based on our business aggregated into two reportable segments according to geography of operations: North American Operations and International Operations as reflected in the table below:
20

Three Months Ended March 31, 2023
Three Months Ended March 31, 2022
(Amounts in thousands)North AmericaInternationalCorporateTotalNorth AmericaInternationalCorporateTotal
Net sales$37,053 $24,625 $— $61,678 $36,288 $24,191 $— $60,479 
Gross margin10,424 8,798 — 19,222 11,713 9,306 21,019 
% of net sales28.1 %35.7 %31.2 %32.3 %38.5 %34.8 %
Selling, general and administrative expenses6,989 6,296 1,823 15,108 6,789 6,282 1,917 14,988 
% of net sales18.9 %25.6 %24.5 %18.7 %26.0 %24.8 %
Restructuring charges— — — — 261 397 — 658 
Operating income (loss)$3,435 $2,502 $(1,823)$4,114 $4,663 $2,627 $(1,917)$5,373 
% of net sales9.3 %10.2 %6.7 %12.9 %10.9 %8.9 %
Add back restructuring charges— — — — 261 397 — 658 
Non-GAAP adjusted operating income$3,435 $2,502 $(1,823)$4,114 $4,924 $3,024 $(1,917)$6,031 
% of net sales9.3 %10.2 %6.7 %13.6 %12.5 %10.0 %
The following table represents key results of operations for nine months ending March 31, 2023 and 2022 based on our business aggregated into two reportable segments according to geography of operations : North American Operations and International Operations:
Nine Months Ended March 31, 2023Nine Months Ended March 31, 2022
(Amounts in thousands)North AmericaInternationalCorporateTotalNorth AmericaInternationalCorporateTotal
Net sales$113,223 $75,691 $— $188,914 $102,763 $80,548 $— $183,311 
Gross margin32,478 28,520 — 60,998 29,568 30,545 — 60,113 
% of net sales28.7 %37.7 %32.3 %28.8 %37.9 %32.8 %
Selling, general and administrative expenses22,164 19,045 5,753 46,962 20,594 19,544 5,611 45,749 
% of net sales19.6 %25.2 %24.9 %20.0 %24.3 %25.0 %
Restructuring charges— 244 — 244 261 397 658 
Gain on sale of building— — — — — — 
Operating income (loss)$10,314 $9,231 $(5,753)$13,792 $8,713 $10,604 $(5,611)$13,706 
% of net sales9.1 %12.2 %7.3 %8.5 %13.2 %7.5 %
Add back restructuring charges— 244 — 244 261 397 — 658 
Non-GAAP adjusted operating income$10,314 $9,475 $(5,753)$14,036 $8,974 $11,001 $(5,611)$14,364 
% of net sales9.1 %12.5 %7.4 %8.7 %13.7 %7.8 %

21

Non-GAAP Measure Reconciliation: Fiscal 2023 Q3 "Currency Neutral" Net Sales
Fiscal YearComparison to three month ending 3/31/2023Fiscal YearComparison to Nine month ending 3/31/2022
(Amounts in Thousands)03/31/202303/31/2022$ Change% Change03/31/202303/31/2022$ Change% Change
Net Sales, as reported$61,678 60,479 1,198 2.0 %$188,914 183,311 5,603 3.1 %
Currency Neutralizing Adjustment*698 — 698 1.2 %1,447 — 1,447 0.8 %
Q3 FY23 Currency Neutral Net Sales62,376 60,479 1,896 3.1 %190,361 183,311 7,050 3.8 %
North America Net Sales, as reported$37,053 $36,288 764 2.1 %$113,223 $102,763 10,460 10.2 %
Currency Neutralizing Adjustment*4 — 4 — %121 — 121 0.1 %
Q3FY23 Currency Neutral North America Net Sales37,057 36,288 768 2.1 %113,344 102,763 10,581 10.3 %
International Net Sales, as reported$24,625 $24,191 434 1.8 %$75,691 80,548 (4,857)(6.0)%
Currency Neutralizing Adjustment*694 — 694 2.9 %1,326 — 1,326 1.6 %
Q3FY23 Currency Neutral International Net Sales25,319 24,191 1,128 4.7 %77,017 $80,548 (3,531)(4.4)%
*"Currency Neutralizing Adjustment" = Change when converting Q3FY23 sales in non USD functional currencies at the same exchange rates used in the comparison period
U.S. GAAP to Non-GAAP Reconciliation: Net Income and Diluted EPS:
Three Months EndedNine Month Ended
03/31/2303/31/202203/31/2303/31/2022
Net income$7,473 $4,284 $12,660 $10,044 
Less tax valuation allowances release(5,000)— (5,000)— 
Add back pension post retirement cost156 (361)459 (1,085)
Non-GAAP adjusted Net Income$2,629 $3,923 $8,119 $8,959 
Shares diluted7,5777,4927,5387,480
Diluted EPS as reported$0.99 $0.57 $1.68 $1.39 
Non-GAAP adjusted diluted EPS $0.35 $0.52 $1.08 $1.20 
Three-months and Nine-months Ended March 31, 2023 and March 31, 2022

Overview

Although backlog was at higher levels in prior quarters, order intake had begun to soften in the quarter ended December 31, 2022 and continued that trend in the quarter ended March 31, 2023. As a result, total backlog was 13.8% lower on March 31, 2023 compared to March 31, 2022. Order intake is down 9.6% for the nine months ended March 31, 2023 compared to the nine months ended March 31, 2022. North America order intake has decreased by 6.8%, and International order intake has decreased by 13.4% for the nine months ended March 31, 2023 compared to the nine months ended March 31, 2022. International order intake has been negatively impacted, particularly in Europe, as a result of recession pressures and the ongoing war in Ukraine. North American order intake has been supported by continued high demand for precision granite products and stable order intake through industrial distribution for our portfolio of precision measuring tools and saw blades.

Net sales in the three months ended March 31, 2023 were $61.7 millions, an increase of $1.2 million, or 2.0% compared to $60.5 million in the three months ended March 31, 2022. Net sales in the nine months ended March 31, 2023 were $188.9 million, compared to $183.3 million for the nine months ended March 31, 2022, representing an improvement of $5.6 million, or 3.1%.

22

Foreign currency translation had a negative impact on sales of $1.4 million over the nine months of fiscal 2023 as the United States Dollar had strengthened compared to other currencies in the first quarter and early second quarter of the fiscal year but had begun to weaken during the latter part of the second and during the third quarters. Currency neutral net sales for the quarter ended March 31, 2023 were $62.4 million , an increase of $1.9 million or 3.1% compared to $60.5 million in the quarter ended March 31, 2022. For the nine months ended March 31, 2023, currency neutral net sales of $190.4 million were an increase of $7.1 million or 3.8% as compared to $183.3 million, for the nine months ended March 31, 2022.

Operating income in the three months ended March 31, 2023 of $4.1 million or 6.7% of sales, was $1.3 million or 23.4% lower than the operating income reported for three months ended March 31, 2022. Operating income in the nine months ended March 31, 2023 of $13.8 million was $0.1 million or 0.6% higher than the same period last year. Restructuring expense included in operating income in the nine months ended March 31, 2023 was $0.2 million or $0.5 million less than the $0.7 million in the nine months ended March 31, 2022. There were no restructuring expenses in the three months ended March 31, 2023 as compared to $0.7 million in the three months ended March 31, 2022.
For the three and nine months ended March 31, 2023 other expense was $0.6 million and $2.4 million, respectively. For the three and nine months ended March 31, 2022 interest income was $0.7 million and $0.2 million, respectively. Other expense is unfavorable in the three months ended and nine months ended March 31, 2023 versus March 31, 2022 by $1.3 million and 2.6 million, respectively. Interest income was $0.1 million unfavorable, interest expense was $0.2 million unfavorable, foreign exchange was $0.3 million unfavorable, pension cost were $0.5 million unfavorable and all other was $0.2 million unfavorable in the three months ended March 31, 2023 as compared to 2022. In the nine months ended March 31, 2023 as compared to 2022 interest income was $0.1 million unfavorable, interest expense was $0.5 million unfavorable, foreign exchange was $0.8 million unfavorable, pension cost were $1.5 million unfavorable and all other was $0.3 million favorable.

Net income for the three months ended March 31, 2023 was $7.5 million and was $3.2 million or 74.4% higher than the Net Income reported for the three months ended March 31, 2022 of $4.3 million.

Net income for the nine months ended March 31, 2023 was $12.7 million, including $0.2 million of restructuring expense as compared to $10.0 million for the nine months ended March 31, 2022 which included $0.7 million of restructuring expense. Diluted earnings per share "EPS" were $0.99 compared to $0.57 in the three months ended March 31, 2022 and $1.68 in the nine months ending March 31, 2023 versus $1.34 in the months ended March 31, 2022. In comparing the same periods for EPS after removing the tax benefit recorded in the March 2023 quarter and the change in pension and post retirement benefit costs, the Non-GAAP adjusted diluted EPS was $0.35 in the three months ended March 31, 2023 versus $0.52 in the three months ended March 31, 2022 and $1.08 in the nine months ended March 31, 2023 and $1.20 in the nine months ended March 31, 2022.

After increasing working capital levels in fiscal 2022 in response to global supply chain and logistics challenges incurred at that time, the Company has engaged in a campaign to reduce working capital levels and improve operating cash flow throughout fiscal 2023. This has culminated in an improved operating cash flow of $19 million through the nine months ended March 31, 2023 compared to the nine months ended March 31, 2022, enabling the company to reduce its debt by $10 million during the three months and $16 million in the nine months ended March 31, 2023.

Net Sales

The Company’s net sales for the three months ended March 31, 2023 were $61.7 million versus $60.5 million for the same period a year prior, an increase of $1.2 million or 2.0%. This increase is primarily driven by an 7.0% increase from price realization offset by a 1.2% decrease due to currency translation and a 3.8% decrease in volume. North America sales of $37.1 million represents an increase of $0.8 million or 2.1% in the quarter ended March 31, 2023, primarily driven by an 10.3% increase from price realization offset by a decrease of 8.2% due to volume. North American net sales have been positively impacted by continued stronger sales of precision granite products and increased sales of precision measuring tools and saw blades as our North American facilities are continuing to recover from the labor shortages experienced a year ago and deliver on the Company's order entry. International Sales increase of 0.4 million or 1.8% to $24.6 million during the quarter ended March 31, 2023 from $24.2 million during the quarter ended March 31, 2022 is driven by an increase of 1.9% due to pricing realization and an increase in volume of 2.7% offset by an unfavorable impact of 2.8% from currency translation.

During nine months ended March 31, 2023 as compared to 2022, North American sales increased $10.5 million or 10.2% while international sales declined $4.9 million or 6.0%. North American sales increased 6.3% due to pricing actions and 4.0% due to volume offset by 0.1% from currency translation, while International sales declined by 17.3% due to volume and 1.6% due to currency translation, but were offset by 12.9% of pricing realization. International net sales have been negatively impacted, particularly in Europe, as a result of recession pressures and the ongoing war in Ukraine. Consolidated Net Sales in the nine
23

months ended March 31, 2023 were $188.9 million, compared to $183.3 million for the same nine months ended March 31, 2022, representing an improvement of $5.6 million, or 3.1%. Overall this was driven by increases due to pricing actions of 9.2% offset by volume reductions of 5.4% and currency translation of 0.8%.

Gross Profit

Gross profit was lower by $1.8 million or 8.5% for the three months, and increased $0.9 million,or 1.5% for the nine months ended March 31, 2023 as compared to the year prior. Gross margin as a percentage of sales decreased 3.6 percentage points for the three months, and decreased 0.5 percentage points for the nine months ended March 31, 2023 compared to the prior year. Gross margin has been impacted by lower factory utilization as a result of lower production as the company has shifted its focus to working capital reduction and cash generation considering overall improved supply chain conditions compared to the prior year.

For the three months ended March 31, 2023, North American gross margin measured as a percent of net sales declined by 4.1 percentage points from 32.3% to 28.1%, compared to the three-month period ended March 31, 2022. For the three month period ended March 31, 2023, North American gross margin was impacted by product mix, the timing of pricing actions and surcharge additions in the comparative quarter ended March 31, 2022 in response to escalating costs at that time, and by lower factory utilization as a result of the company's prioritization of working capital reduction and cash generation. International gross margin decreased by 2.7 percentage points, from 38.5% during the three-month period ended March 31, 2022 to 35.7% for the three-month period ended March 31, 2023. International gross margins have also been impacted by lower factory utilization as a result of lower production as the company has shifted its focus to working capital reduction and cash generation considering overall improved supply chain conditions compared to the prior year.

For the nine months ended March 31, 2023 and 2022, North American gross margin measured as a percentage of Net Sales were 28.7% and 28.8%. International gross margin as a percentage of net sales for the nine months ended March 31, 2023 and 2022 were and 37.7% and 37.9% , respectively.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 0.8% during the quarter ended March 31, 2023 to $15.1 million compared to the quarter ended March 31, 2022, representing 24.5% of Net Sales for the quarter ended March 31, 2023 compared to 24.8% in the prior year quarter ended March 31, 2022 .

Selling, general and administrative expenses increased $1.2 million or 2.7% during nine months ended March 31, 2023 compared to 2022, however as a percentage of net sales it has declined from 25.0% for the nine months ended March 31, 2022 to 24.9% for the nine months ended March 31, 2022.

Other Income (Expense)

For the three and nine months ended March 31, 2023 other expense was $0.6 million and $2.4 million, respectively. For the three and nine months ended March 31, 2022 interest income was $0.7 million and $0.2 million, respectively. Other expense is unfavorable in the three months ended and nine months ended March 31, 2023 versus March 31, 2022 by $1.3 million and 2.6 million, respectively. Interest income was $0.1 million unfavorable, interest expense was $0.2 million unfavorable, foreign exchange was $0.3 million unfavorable, pension cost were $0.5 million unfavorable and all other was $0.2 million unfavorable in the three months ended March 31, 2023 as compared to 2022. In the nine months ended March 31, 2023 as compared to 2022 interest income was $0.1 million unfavorable, interest expense was $0.5 million unfavorable, foreign exchange was $0.8 million unfavorable, pension cost were $1.5 million unfavorable and all other was $0.3 million favorable.

Income Taxes

In the three months ended March 31, 2023, the Company recognized income tax benefit of $4.0 million on profit before tax of $3.5 million (an effective tax rate of 113%) as compared to income tax expense of $1.8 million on profit before tax of $6.1 million (an effective tax rate of 29%), in the three months ended March 31, 2022.

In the nine months ended March 31, 2023, the Company recognized income tax benefit of $1.3 million on profit before tax of $11.4 million (an effective tax rate 11%) as compared to income tax expense of $3.9 million on profit before tax of $14.0 million (an effective tax rate of 28%), in the nine months ended March 31, 2022.

24

The lower effective tax rate in the three and nine months ended March 31, 2023, when compared with the three and nine months ended March 31, 2022, respectively, is primarily due to the discrete tax benefit of $5.0 million recognized for the release of valuation allowance against a portion of its U.S. deferred tax assets. At the end of each reporting period management considers all evidence, both positive and negative, that could affect the view of the future realization of deferred tax assets. Based upon cumulative profitability in the US and increases in future taxable income projections, management has determined during the three months ended March 31, 2023, there is sufficient positive evidence to release a portion of valuation allowance previously provided against its foreign tax credits and certain state net operating losses. In the three and nine months ended March 31, 2023, the Company also recognized a discrete tax benefit of $0.2 million for historic transfer pricing adjustments due to the lapse of the statute of limitations of certain foreign subsidiaries.

Excluding the tax benefit recognized for the release of valuation allowance, the effective tax rate in the three and nine months ended March 31, 2023 is higher than the effective tax rate for the three and nine months ended March 31, 2022, respectively, primarily due to final U.S. foreign tax credit regulations effective in fiscal 2023 that result in an increase in tax expense from the GILTI inclusion of approximately $0.1 million and $0.5 million, respectively, as a result of this change.


LIQUIDITY AND CAPITAL RESOURCES
Cash flows (in thousands)Nine Months Ended
03/31/202303/31/2022
Cash provided by (used in) operating activities$15,897 $(2,791)
Cash (used in) provided by investing activities(5,639)(7,665)
Cash (used in) provided by financing activities(16,209)10,464 
Effect of exchange rate changes on cash23 (1,093)
Net (decrease) in cash$(5,928)$(1,085)

Net cash flows for the nine months ended March 31, 2023 provided a decrease in cash of $5.9 million compared to a decrease in cash of $1.1 million for the nine months ended March 31, 2022. The Company paid down $16.2 million in debt and cash provided by operations was $15.9 million. Net income of $8.0 million and accounts receivable change of $7.2 million were partially offset by other working capital requirements of $6.8 million while other non-cash operating activities totaled $6.8 million. The Company reduced inventory levels in the three months ended March 31, 2023 by $2.4 million and softer order entry lowered manufacturing utilization in the period. Inventory levels increased $0.8 million during the nine months ended March 31, 2023.
After increasing working capital levels in fiscal 2022 in response to global supply chain and logistics challenges incurred at that time, the Company has engaged in a campaign to reduce working capital levels and improve operating cash flow throughout fiscal 2023. This has culminated in an improved operating cash flow of $19.0 million through the nine months ended March 31, 2023 compared to the nine months ended March 31, 2022, enabling the company to reduce its debt by $10 million during the three months and $16 million in the nine months ended March 31, 2023.

The Company believes it maintains sufficient liquidity and has the resources to fund its operations and cash expected to be provided by future operating activities are adequate to satisfy working capital, capital expenditure requirements and other contractual obligations for at least the next 12 months from the date of the financial statements included in this Quarterly Report on Form 10-Q.
On April 29, 2022, the Company and certain of the Company’s domestic subsidiaries entered into a new Loan and Security agreement (the "Loan and Security Agreement") with HSBC Bank USA. These new credit facilities ("the facilities") replaced the Company’s previous TD Bank credit facilities and are comprised of a $30 million revolving line of credit with a $10 million uncommitted accordion provision, a $12.1 million term loan and a $7 million capital expenditure draw down credit facility. The Facilities are secured by a valid first-priority security interest on substantially all existing and future assets of the Company and its domestic subsidiaries. At March 31, 2023 the Company has excess availability on the revolving line of credit and the capital expenditure drawn down facility of $27.3 million.
25

The Company has approved a $5 million dollar expansion at our precision granite manufacturing facility in Waite Park, MN in order to meet continued high demand for its products anticipated over the next several years. The project is expected to continue throughout fiscal 2023 and into the first quarter of fiscal 2024, and will be financed by use of the $7 million capital expenditure draw down facility which remains unused, and a combination of the revolving line of credit and current cash availability.
The effective interest rate on the borrowings under the Loan and Security Agreement during the nine months ended March 31, 2023 and 2022 was 5.5% and 1.9% respectively.

The Company does not have any material off-balance sheet arrangements as defined under the Securities and Exchange Commission rules.
ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
One should carefully review and consider the information regarding certain factors which could materially affect our business, financial condition or future results set forth under Item 1A. “Risk Factors” in our Form 10-K for the year ended June 30, 2022.
ITEM 4.    CONTROLS AND PROCEDURES
The Company's management, under the supervision and with the participation of the Company's President and Chief Executive Officer and Chief Financial Officer and Treasurer, has evaluated the Company's disclosure controls and procedures as of March 31, 2023, and they have concluded that our disclosure controls and procedures were effective as of such date. All information required to be filed in this report was recorded, processed, summarized and reported within the time period required by the rules and regulations of the Securities and Exchange Commission, and such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the three months ended March 31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
26

PART II.    OTHER INFORMATION
ITEM 1.    LEGAL PROCEEDINGS

In the ordinary course of business, we are from time to time involved in lawsuits, claims, investigations, proceedings, and threats of litigation relating to intellectual property, commercial arrangements and other matters. We do not believe we are currently party to any pending legal action, arbitration proceeding or governmental proceeding, the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business or operating results. We are not a party to any material proceedings in which any director, member of senior management or affiliate of ours is either a party adverse to us or our subsidiaries or has a material interest adverse to us or our subsidiaries.

ITEM 1A.    RISK FACTORS

There have been no material changes from the risk factors set forth in the Company’s Annual Report on Form 10-K
for the year ended June 30, 2022.
27

ITEM 6.    EXHIBITS
Exhibit Number
Description of Exhibit
3aRestated Articles of Organization as amended, filed with Form 10-K for the year ended June 30, 2012 filed September 12, 2012, is hereby incorporated by reference.
3bAmended and Restated Bylaws, filed with Form 10-Q for the quarter ended December 31, 2012 filed February 7, 2013, is hereby incorporated by reference
4aRights Agreement dated as of November 2, 2010 between the Company and Mellon Investor Services LLC, as Rights Agent (together with exhibits, including the Form of Rights Certificate, and the Summary of Rights to Purchase Shares of Class A Common Stock), filed with Form 10-Q for the quarter ended September 25, 2010, filed November 4, 2010 is hereby incorporated by reference.
4bAmendment No. 1 to Rights Agreement dated as of February 5, 2013 by and between the Company and Computershare Shareowner Services LLC, filed with Form 10-Q for the quarter ended December 31, 2012, filed February 7, 2013 is hereby incorporated by reference.
31.1*
31.2*
32.1+
101
The following materials from The L. S. Starrett Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 are furnished herewith, formatted in XBRL (Extensible Business Reporting Language): (I) the Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss), (iv) the Condensed Consolidated Statement of Stockholders' Equity, (v) the Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
* Filed herewith.
+ Furnished, not filed.
28

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
THE L. S. STARRETT COMPANY
(Registrant)
DateMay 8, 2023/S/R. Douglas A. Starrett
Douglas A. Starrett - President and CEO (Principal Executive Officer)
DateMay 8, 2023/S/R. John C. Tripp
John C. Tripp - Treasurer and CFO (Principal Accounting Officer)

29
LS Starrett (NYSE:SCX)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 LS Starrett 차트를 더 보려면 여기를 클릭.
LS Starrett (NYSE:SCX)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 LS Starrett 차트를 더 보려면 여기를 클릭.